Search results for "coronary syndrome"

showing 10 items of 281 documents

Les anti-agrégants plaquettaires au cours du syndrome coronarien aigu. Données des grandes études

2010

Cardiovascular disease is the leading cause of early death and morbidity in developed countries and is becoming a growing problem in many developing countries. Currently, anti-coagulants play a major role in the management of the acute phase in association or not with reperfusion strategies. The combination of clopidogrel and aspirin, in accordance with the results of large randomized trials, is the treatment of reference. However two new drugs, a thienopyridine (prasugrel), and a cyclo-pentyl-triazolo-pyridine (ticagrelor) have shown their interest in major studies in comparison with clopidogrel. As a result, several effective P2Y12 receptor antagonist anti-platelet agents are now availabl…

medicine.medical_specialtyAspirinAcute coronary syndromePrasugrelThienopyridinebusiness.industryClopidogrelmedicine.diseaseSurgeryClinical trialmedicineMedical prescriptionCardiology and Cardiovascular MedicineIntensive care medicinebusinessTicagrelormedicine.drugAnnales de Cardiologie et d'Angéiologie
researchProduct

Left bundle branch block and myocardial infarction, a diagnosis not always easy: Our experience and review of literature

2012

The occurrence of left bundle branch block (LBBB) is quite common in clinical practice. The changes in cardiac repolarization, caused by this disorder of electric conduction, may mask the presence of an acute myocardial infarction (AMI), delaying the diagnostic-therapeutic iter, with an important impact on prognosis. We describe the case of a woman of 59 years with LBBB, came to our observation for a constrictive chest pain associated with dyspnea. The diagnostic workup for suspected acute coronary syndrome (ACS), initially conducted only on the analysis of the electrocardiogram (negative TnI at entry), showed the presence of coronary arteries free of stenosis. However, the diagnostic confi…

Left Bundle Branch Block (LBBB)medicine.medical_specialtyAcute coronary syndromebusiness.industryLeft bundle branch blockMyocardial InfarctionElectrocardiography in myocardial infarctionmedicine.diseaseChest painElectrocardiogramCoronary arteriesStenosismedicine.anatomical_structureInternal medicinemedicineCardiologyIn patientcardiovascular diseasesMyocardial infarctionmedicine.symptombusinessWorld Journal of Cardiovascular Diseases
researchProduct

Impact of Frailty and Other Geriatric Syndromes on Clinical Management and Outcomes in Elderly Patients With Non-ST-Segment Elevation Acute Coronary …

2016

The incidence of acute coronary syndromes (ACS) is high in the elderly. Despite a high prevalence of frailty and other aging-related variables, little information exists about the optimal clinical management in patients with coexisting geriatric syndromes. The aim of the LONGEVO-SCA registry (Impacto de la Fragilidad y Otros Sindromes Geriatricos en el Manejo y Pronostico Vital del Anciano con Sindrome Coronario Agudo sin Elevacion de Segmento ST) is to assess the impact of aging-related variables on clinical management, prognosis, and functional status in elderly patients with ACS. A series of 500 consecutive octogenarian patients with non-ST-segment elevation ACS from 57 centers in Spain …

medicine.medical_specialtyAcute coronary syndromebusiness.industryIncidence (epidemiology)General Medicine030204 cardiovascular system & hematologymedicine.diseaseComorbidityAngina03 medical and health sciences0302 clinical medicineQuality of lifeEmergency medicinemedicinePhysical therapy030212 general & internal medicineDisease management (health)Cardiology and Cardiovascular MedicineProspective cohort studybusinessSurvival rateClinical Cardiology
researchProduct

Differences in Symptomatology and Clinical Course of Acute Coronary Syndromes in Women ≤45 Years of Age Compared to Older Women

2021

Acute coronary syndromes (ACS) in young people are rare. The data regarding differences in symptoms in relation to age are scarce, which may have an influence on outcomes. The aim of this study was to evaluate the differences in the clinical course of ACS between younger women (≤45 years old) and older women (63-64 years old). We compared 7481 women with ACS from the Polish Registry of ACS between 2007 and 2014 (1834 women aged ≤45 years and 5647 women aged 63-64 years). The predominant symptom of ACS in both groups was chest pain, with a higher incidence occurring in younger women (90.4% vs 88.5%, P = 0.025). Prehospital cardiac arrest occurred more often in younger women (2.1% vs 0.8%, P0…

Pediatricsmedicine.medical_specialtyAdolescentMEDLINE030204 cardiovascular system & hematologyChest pain03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicinemedicineHumans030212 general & internal medicineAcute Coronary SyndromeAgedbusiness.industryIncidence (epidemiology)Age FactorsClinical courseGeneral MedicineMiddle AgedCoronary VesselsTreatment OutcomeST Elevation Myocardial InfarctionFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCurrent Problems in Cardiology
researchProduct

Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB regis…

2021

Abstract Objectives To identify potential differences in 2‐year outcome between patients who underwent coronary revascularization using bioresorbable vascular scafffolds (BVS) in stable coronary artery disease (CAD) and acute coronary syndromes (ACS). Background Data from randomized trials suggest a significantly higher event rate following coronary revascularization using everolimus‐eluting BVS as compared to new generation drug eluting stents. Whether particular patient subgroups are at increased risk for scaffold thrombosis and target lesion failure (TLF) has not clearly been demonstrated. Methods German‐Austrian ABSORB RegIstRy is a prospective all‐comer multi‐center observational study…

Target lesionmedicine.medical_specialtyTime FactorsMedizinCoronary Artery Disease030204 cardiovascular system & hematologyProsthesis Designlaw.inventionCoronary artery disease03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineRandomized controlled triallawInternal medicineAbsorbable ImplantsmedicineHumansRadiology Nuclear Medicine and imagingIn patientEverolimusProspective StudiesRegistries030212 general & internal medicineddc:610Acute Coronary SyndromeEverolimusbusiness.industryGeneral Medicinemedicine.diseaseThrombosisStenosisTreatment OutcomeAustriaCardiologyCardiology and Cardiovascular MedicinebusinessMacemedicine.drug
researchProduct

Usefulness of Clinical Data and Biomarkers for the Identification of Frailty After Acute Coronary Syndromes

2015

Abstract Background Frailty predicts mortality after acute coronary syndrome (ACS). The standard frailty scales, such as the Fried score, consist of a variety of questionnaires and physical tests. Our aim was to investigate easily available clinical data and blood markers to predict frailty at discharge, in elderly patients after ACS. Methods A total of 342 patients older than 65 years, survivors after ACS, were included. A high number of clinical variables were collected. In addition, blood markers potentially linked to frailty and related to the processes of inflammation, coagulation, hormonal dysregulation, nutrition, renal dysfunction, and heart dysfunction were determined. Frailty was …

Malemedicine.medical_specialtyAcute coronary syndromeFrail ElderlyMyocardial InfarctionComorbidityDiseaseCohort StudiesRisk FactorsInternal medicineVitamin D and neurologyHumansMedicineMyocardial infarctionAcute Coronary SyndromeCystatin CVitamin DGeriatric AssessmentAgedAged 80 and overbusiness.industryPrognosismedicine.diseaseComorbidityPatient DischargeSurgeryPatient Outcome AssessmentHeart failureHemoglobinometryBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesCohort studyCanadian Journal of Cardiology
researchProduct

YKL-40 as a predictor of mortality after acute coronary syndrome

2020

medicine.medical_specialtyAcute coronary syndromebusiness.industryMEDLINEAdipokinemedicine.diseaseGastroenterologyAdipokinesLectinsInternal medicineInternal MedicinemedicineHumansChitinase-3-Like Protein 1Acute Coronary SyndromeChitinase-3-Like Protein 1businessPolish Archives of Internal Medicine
researchProduct

The implication of MBL deficient haplotypes in acute coronary syndrome

2014

haplotypeSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaPhysiologyPhysiology (medical)mannose binding lectin 2mannose binding lectin 2 DNA acute coronary syndrome genetic polymorphism haplotypegenetic polymorphismDNACardiology and Cardiovascular Medicineacute coronary syndrome
researchProduct

2014

Introduction Particularly in the setting of acute coronary syndromes, the interplay between vascular and platelet function has been postulated to have direct clinical implications. The present trial is designed to test the effect of clopidogrel, prasugrel and ticagrelor on multiple parameters of vascular function, platelet aggregation, oxidative and inflammatory stress before and up to 4 weeks after coronary artery stenting. Methods and analysis The study is designed as a three-arm, parallel design, randomised, investigator-blinded study. Patients with unstable angina or non-ST elevation myocardial infarction undergoing coronary intervention with a drug-eluting stent will be randomised to r…

Acute coronary syndromemedicine.medical_specialtyPrasugrel HydrochloridePrasugrelUnstable anginabusiness.industryGeneral MedicineClopidogrelmedicine.diseaseInternal medicinemedicineCardiologyPlatelet aggregation inhibitorTiclopidinebusinessTicagrelormedicine.drugBMJ Open
researchProduct

Cardiac Computed Tomography Angiography Follow-Up of Resorbable Magnesium Scaffolds.

2021

Abstract Introduction An ancillary advantage of bioresorbable scaffolds is the possibility of non-invasive imaging assessment of the treated coronary segment. Cardiac computed tomography angiography (CCTA) studies of resorbable magnesium scaffolds (RMS) are scarce. Methods In this collaborative, international study, nine patients who had an RMS implanted underwent CCTA as part of follow-up assessment. Core-lab blinded quantitative and qualitative assessment was performed by an independent CCTA investigator. Results Eight studies were amenable for quantitative analysis, and the blinded CT investigator successfully located and evaluated patency of RMS in all cases. The CCTA follow-up in-scaff…

Acute coronary syndromeComputed Tomography AngiographyLate lossCoronary Artery Disease030204 cardiovascular system & hematologyCoronary Angiography03 medical and health sciences0302 clinical medicineCardiac computed tomography angiographyFibrous plaqueMedicineHumansMagnesium030212 general & internal medicinebusiness.industryGeneral Medicinemedicine.diseaseStenosisDiameter stenosisCoronary vesselCardiology and Cardiovascular MedicineNuclear medicinebusinessTomography X-Ray ComputedBioresorbable scaffoldFollow-Up StudiesCardiovascular revascularization medicine : including molecular interventions
researchProduct